Replimune Group, Inc. - Common Stock — 분기별 재무 통계 (NASDAQ:REPL) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 -53.73 M-77.02 M-81.21 M-65.95 M -277.91 M 투자 활동으로 인한 현금 -7.7 M65.05 M84.17 M75.12 M 216.64 M 재무활동으로 인한 현금 -132 K-158 K324 K10.45 M 10.48 M 잉여 현금 흐름 -54.87 M-79.76 M-82.56 M-66.09 M -283.27 M

뉴스

Biotech Investors Are Tuning Out the MAHA Chaos

What's Going On With Replimune Stock On Tuesday? - Replimune Group (NASDAQ:REPL)

Replimune stock collapses 64% following FDA rejection

Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

FDA Rejection Sparks Questions On Replimune Drug Approval Path - Replimune Group (NASDAQ:REPL)

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Replimune: Second CRL May Have Sealed RP1's Fate - It's Hard To See Positives (REPL)

FDA Review Looms As Replimune Faces Weak Technical Setup - Replimune Group (NASDAQ:REPL)

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

CORT Rises on FDA Nod to Lifyorli in Platinum-Resistant Ovarian Cancer